Freenome (FRNM) stock

Cancer detection tests , market cap $1.1B

Blood-based tests for early cancer detection

Worth $1.1B

$10.77

+1.89%

As of Tuesday's close · Live for Pro members at the open

Quality Score

-3

Poor

In its industry

#17of 18

Diagnostics

Checks firing

1of 14

Trending down

From its high

-38.5%

under its best since listing

FRNM's Quality Score was unchanged on Tue, Nov 10, at -3.

New listing, trading since Jul 21, 2026. 80 trading days so far, so 3 of the 14 chart checks wait for more history.

See FRNM's 14 chart checksSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Key facts on FRNM

Key facts on FRNM
Holding it back	Moves 9.4% a day with no profit behind it
Latest filing	8-K, Nov 10 Reported its quarterly results

1 more reason behind FRNM's -3, free with an account →1 more reason behind FRNM's -3, for Pro members.

FRNM in the news

ReportToday after the close: a profit of $0.58 a share. Past reports ›

FRNM catalysts

Why FRNM scores -3

Poorfor quality, not price, 1 of 14 chart checks firingWhat the Quality Score means

+1Chart checks 1 of 14 firing right now, one point each
−2Volatility moves 9.4% a day on a $763K loss over four quarters, with no positive free cash flowA daily range of 5% or more with nothing behind it (no profit or cash flow, sales shrinking, or 10% more shares outstanding with no free cash flow): -1, or -2 from 8%.

Profit subtractsRead on the last four quarters against the four before, or the last full year where no quarters are filed.
Cash flow subtracts-1 when free cash flow over the last four quarters is negative.

No effect today: Long-term trend, Run-up, Size, Growth, Dilution, Persistence, and News.

What every line is worth, and the reason behind it, on FRNM and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 10:56 PM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Alert me when FRNM's Quality Score turns up

A free account. No card.

How FRNM ranks in Diagnostics

FRNM is #17 of 18 by Quality Score.

How FRNM ranks in Diagnostics
Rank	Stock	Checks	Quality Score
1	CDNACareDx	4/14	16
2	BLLNBillionToOne	5/14	16
3	LHLabcorp	7/14	16
	CSTLCastle Biosciences		Open for its score
	DGXQuest Diagnostics		Open for its score
	GHGuardant Health		Open for its score
	GRALGRAIL		Open for its score
17	FRNMFreenome	1/14	-3

FRNM has 1 of 14 chart checks firing

Trend1 of 5 shown

MA FAN 21 EMA W.EMA HH/HL 52W HI

Volume1 of 3 shown

VOL VDU U/D VOL

Tight range1 of 3 shown

ATR SQZ SQUEEZE NR7

Buying1 of 3 shown

OBV+CLOSE HI SPRING

The other 10 checks on FRNM, and all 14 on every stock.Get in free →

FRNM RSI today: 34.6, below its 50-day average

Not scored

RSI 34.6, MACD below signal. Not scored.13 readings

The deep dive on FRNM

What it does and how it makes money2 findingsFor Pro members2 findings on what FRNM does and how it makes money, for Pro members
Where it stands3 findingsAt the past year's pace of $227K a quarter, its $437K in cash covers about 2 quarters. Arithmetic on filed figures, not a forecast.Balance sheet of Jun 30, 2026, filed Jul 15, 2026
Who holds and trades it2 findingsFor Pro members2 findings on who holds and trades FRNM, for Pro members

6 more findings on FRNM, each with its source, for Pro members.

FRNM's officers and directors

Officers and directors with a Form 4 in the last 12 months.

Aaron Matthew ElliottChief Executive Officer · no trades on file

See insider trades by person

About Freenome

Freenome Inc is a development-stage, early cancer detection company developing blood-based screening tests leveraging a proprietary artificial intelligence/machine learning multiomics technology platform to transform multi-cancer and ultimately multi-disease detection. It is developing a range of blood-based cancer screening tests.

New York, NYfreenome.com

Here is what Pro members see.

The same page for Pro members, on Microsoft
Its Quality Score and rank, the line that drives it, and the live price.
The full chart
A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.
Every line of the score
Price action, the company, and signals, each with its points, on FRNM and every other stock.
CEOs buying their own stock
Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.
Congress trades
A member's trades, newest first, each with its amount. Sort and filter the whole list.
14 chart checks, read for you
The ones firing on the stock, each in plain words, its rule a tap away.
Earnings, week by week
Who reports each day, and how each stock took its last four reports.
FDA dates, counted down
Each date in the company's words, its cash against the date, and an optional alert before it.
The market map
Every stock a box, colored by its Quality Score.
Themes, ranked live
Each theme's stocks ranked by Quality Score, live. Here, AI chips.
The top 10, every day
The ten highest Quality Scores at each close, kept day by day, week by week.
Optional alerts, your way
Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.
Your watchlist, scored
Your stocks by Quality Score, today's move, or name.
On your phone and your laptop
The same account and watchlist on both, each laid out for its screen.

Prices refresh every 2.5 seconds during market hours.
Optional alerts by push, email, or the bell.
Add it to your Home Screen and it opens like an app.

Pro members see every line of every stock's score.

What would turn FRNM's score around: 5 things
2 more filings explained, a plain line each
Real-⁠time prices, no delay

See FRNM's 14 chart checks

See it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Straight AnswersStraight Answers

As of Nov 10, 2026: FRNM's Quality Score is -3 (Poor), #17 of 18 in Diagnostics.

What does FRNM's Quality Score say?

FRNM scores -3 today, which Breakaway calls Poor. It is #17 of 18 in Services-⁠Medical Laboratories by Quality Score, with 1 of 14 chart checks firing. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is FRNM's Quality Score?

FRNM scores -3 today, which Breakaway calls Poor (below zero). That is #17 of 18 in Services-⁠Medical Laboratories by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind FRNM's -3.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

FRNM catalysts

Why FRNM scores -3 ›

How FRNM ranks in Diagnostics ›

FRNM has 1 of 14 chart checks firing ›